TRiCares SAS has enrolled and treated the first patient in its TRICURE US IDE pivotal study of the Topaz TTVR...
Quoin Pharmaceuticals has received FDA clearance for its IND application for QRX003, enabling it to initiate a Phase II clinical...
Apertura has entered a CRADA with various NIH institutes for a gene therapy to treat Niemann-Pick Disease Type C1 (NPC1).The...
Philips has expanded its ultrasound portfolio with the launch of the Alturion system, which features AI-powered workflows and is intended...
Mighty Therapeutics has dosed the first patient in 4TAZPower, its global Phase IV confirmatory study assessing Forzinity injection in those...
Evogene and Tel Aviv University’s BCDD have partnered to expedite small-molecule drug discovery originating from Israeli academic research.The post Evogene...
AtaCor Medical has enrolled the first patient in its ALARION-EV pivotal trial, which is evaluating an investigational EV-ICD system.The post...
Prilenia Therapeutics and Ferrer have begun the confirmatory Phase III PRECISE-HD trial assessing pridopidine as a potential treatment for HD.The...
Biocytogen and Whitehawk Therapeutics are set to develop bispecific antibody-drug conjugates (BsADCs), as part of a global partnership.The post Biocytogen...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.